However, when hsa-miR-193b-3p was overexpressed, we observed a decreasing trend in SLC2A2/GLUT2 expression, suggesting lower glucose uptake, which may contribute to hyperglycemia, a feature associated with the plasma increase in hsa-miR-193b-3p in humans. The gene discussed is SLC2A2; the disease is Hyperglycemia.